This report covers the period from 2017 to 2024, during which the programme expanded from 10 to 13 authorities, including Health Canada, PMDA Japan, and ANVISA Brazil.
The COVID-19 pandemic significantly disrupted on-site inspections activities but also accelerated the adoption of remote inspections and reinforced reliance-based approaches.